Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT01291927
Eligibility Criteria:
Inclusion Criteria:
* Pathologically proven periampullary carcinoma (including cancers of distal common bile duct, ampulla or papilla of Vater)
* Pre- and intra-operative stage(CT, EU stage):pTis or pT1 or pT2, N0 or N1, M0
* ASA score: \< 3
* Liver function:Child-Pugh A
* No history of other cancers
* No history of preoperative chemotherapy or radiotherapy
* Written informed consent
Exclusion Criteria:
* There are concurrent cancers or the patients have been treated due to other type of cancers before diagnosed as periampullary carcinoma
* Pre- and intra-operative stage: more advanced than T2,or with remote metastasis
* The Patients received other non-surgical therapy, such as chemotherapy, immunotherapy, radiotherapy or endoscopic therapy
* The Patients received upper abdominal surgery
* ASA score: ≥ 3
* Liver function:Child-Pugh B or C
* Pregnancy patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01291927
Study Brief:
Protocol Section:
NCT01291927